<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Allergy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Allergy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский Аллергологический Журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1810-8830</issn><issn publication-format="electronic">2686-682X</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">274</article-id><article-id pub-id-type="doi">10.36691/RJA274</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">CELL PENETRATING PEPTIDE COMPLEXED WITH SIRNA TARGETED TO IL-4 DECREASE AIRWAY INFLAMMATION AND AIRWAY HYPER RESPONSIVENESS IN A MOUSE MODEL OF ALLERGIC ASTHMA</article-title><trans-title-group xml:lang="ru"><trans-title>Комплекс катионного пептида и молекул миРНК против ИЛ-4 эффективно снижают гиперреактивность бронхов и аллергическое воспаление на мышиной модели бронхиальной астмы</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shilovskiy</surname><given-names>I P</given-names></name><name xml:lang="ru"><surname>Шиловский</surname><given-names>И П</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sundukova</surname><given-names>M S</given-names></name><name xml:lang="ru"><surname>Сундукова</surname><given-names>М С</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gaisina</surname><given-names>A R</given-names></name><name xml:lang="ru"><surname>Гайсина</surname><given-names>А Р</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zaretskaya</surname><given-names>V A</given-names></name><name xml:lang="ru"><surname>Зарецкая</surname><given-names>М А</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kamyshnikov</surname><given-names>O Y</given-names></name><name xml:lang="ru"><surname>Камышников</surname><given-names>О Ю</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Khaitov</surname><given-names>M R</given-names></name><name xml:lang="ru"><surname>Хаитов</surname><given-names>М Р</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia</institution></aff><aff><institution xml:lang="ru">ФГБУ «ГНЦ Институт иммунологии» ФМБА России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2017-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2017</year></pub-date><volume>14</volume><issue>1S</issue><issue-title xml:lang="en">VOL 14, NOS1 (2017)</issue-title><issue-title xml:lang="ru">ТОМ 14, №S1 (2017)</issue-title><fpage>204</fpage><lpage>205</lpage><history><date date-type="received" iso-8601-date="2020-03-10"><day>10</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2017, Pharmarus Print Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2017, Фармарус Принт Медиа</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="en">Pharmarus Print Media</copyright-holder><copyright-holder xml:lang="ru">Фармарус Принт Медиа</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2021-11-01"/></permissions><self-uri xlink:href="https://rusalljournal.ru/raj/article/view/274">https://rusalljournal.ru/raj/article/view/274</self-uri><abstract xml:lang="en"><p/></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Holgate S.T. The sentinel role of the airway epithelium in asthma pathogenesis. // Immunol. Rev. 2011. Vol. 242, № 1. P. 205-219.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Grünig G. et al. Requirement for IL-13 independently of IL-4 in experimental asthma. // Science. 1998. Vol. 282, № 5397. P. 2261-2263.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Perkins C., Wills-Karp M., Finkelman F.D. IL-4 induces IL-13-independent allergic airway inflammation. // J. Allergy Clin. Immunol. 2006. Vol. 118, № 2. P. 410419.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Maes T., Joos G.F., Brusselle G.G. Targeting interleukin-4 in asthma: lost in translation? // Am. J. Respir. Cell Mol. Biol. 2012. Vol. 47, № 3. P. 261-270.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Chatila T.A. Interleukin-4 receptor signaling pathways in asthma pathogenesis // Trends in Molecular Medicine. 2004. Vol. 10, № 10. P. 493-499.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Шиловский И.П. и др. Интерференция РНК -новый подход в терапии аллергической бронхиальной астмы // Экспериментальная и клиническая фармакология. 2016. Vol. 79, № 4. P. 35-44.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Koloskova O.O. et al. Synthesis and evaluation of novel lipopeptide as a vehicle for efficient gene delivery and gene silencing // Eur J Pharm Biopharm. 2016. Vol. 102. P. 159-167.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Шиловский И.П. и др., Разработка модели РНКи-опосредованной супрессии гена интерлейкина-4 in vitro // Физиология и патология иммунной системы. 2011. Vol. 15, № 6. P. 3-12.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Шиловский И.П. и др., Синтетические siRNA эффективно подавляют экспрессию провоспалительного цитокина интерлейкина-4 мыши in vitro // Иммунология. 2012. Vol. 2. P. 66-70.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Шиловский И.П. и др., Разработка безадъювантной модели хронической бронхиальной астмы у мышей // Российский иммунологический журнал. 2014. Vol. 3, № 17. P. 638-641.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Shilovskiy I.P. et al. Adjuvant and adjuvant-free protocols produce similar phenotypes of allergic asthma in mice // Curr. Trends Immunol. 2015. Vol. 16. P. 79-91.</mixed-citation></ref></ref-list></back></article>
